Dr. Babak Hajhosseini is a world-renowned physician-scientist, and wound healing specialist. He is the Founder, President, and Chief Executive Officer of Wound and Burn Centers of America. Dr. Hajhosseini is a Diplomate of the American Board of Wound Management and a member of several prestigious medical associations, including the Wound Healing Society, American Burn Association, American Society of Plastic Surgeons, American College of Surgeons, American Medical Association, and The Undersea and Hyperbaric Medical Society.
Meet Our Founder, President, and CEO
Fellowships & Specialization
With 16 years of medical education and training, Dr. Hajhosseini has completed two clinical fellowship programs in “complex wound healing” and “burn surgery” at renowned academic institutions, including Stanford University. His contributions to the field of wound healing have been substantial. He has pioneered innovative techniques, discovered new applications for treatment modalities such as Hyperbaric Oxygen Therapy and Laser Therapy, made groundbreaking advances in Regenerative Medicine, and developed management guidelines widely adopted by experts in the field.
Professional Recognition
Dr. Hajhosseini has authored two book chapters and over 30 peer-reviewed publications. He also serves as an Ad Hoc Reviewer for The Lancet, the world’s highest-impact academic journal. He has been awarded Co-Investigator and Key Collaborator in four Federal Grants and entrusted with designing and conducting over 10 Clinical Trials related to wound healing. His scientific work has been cited more than 750 times by his peers in medical literature.
Medical Board Certification
American Board of Wound Management
Medical License
State of California
Clinical Fellowship
Advanced Wound Healing
Stanford University School of Medicine, Division of Plastic and Reconstructive Surgery
Clinical Fellowship, Burn Surgery
Stony Brook Medicine, Division of Plastic and Reconstructive Surgery
New York Plastic Surgical Group, a Division of Long Island Plastic Surgical Group
Nassau University Medical Center, Division of Plastic and Reconstructive Surgery
Post-Doctoral Research Fellowship
Distinguished Scholar
Center for Special Minimally Invasive and Robotic Surgery
Stanford University School of Medicine
Residency, General Surgery
Stanford University School of Medicine
David Geffen School of Medicine at UCLA
Internship, General Surgery
Keck School of Medicine of the University of Southern California
Medical School Training
Tabriz University of Medical Sciences (Graduated with High Honors)
Professional Society Memberships:
- American Board of Wound Management (Diplomate)
- Wound Healing Society
- American Burn Association
- American Society of Plastic Surgeons
- American College of Surgeons
- American Medical Association
- The Undersea and Hyperbaric Medical Society
Editorial Appointments
(Ad Hoc Reviewer):
- The Lancet
- Annals of Surgery
- Journal of the American College of Surgeons
- British Journal of Surgery
Federal Grants
(Co-Investigator & Key Collaborator):
- Diabetic Foot Ulcer Consortium Clinical Research Unit
- Prevention of Scar Formation in the Skin using a Topical Focal Adhesion Kinase Inhibitor
- Targeted Delivery of a Small Molecule Focal Adhesion Kinase Inhibitor for Scarless Wound Healing
- Diabetic Foot Ulcer Recurrence
Selected Clinical Trials:
- Autologous Regenerative Technology (ART) For Wound Healing
- Dose-response relationship study of S42909 on leg ulcer healing after oral repeated administration in patients with an active venous leg ulcer. A 10-week randomized, double-blind, placebo-controlled, prospective, international, multicentre, phase IIa study
- Chronic wound treatment with the Avazzia stimulation device
- A Multicenter, Randomized, Single-Blind Study with an Open-Label Extension Option to Further Evaluate the Safety and Efficiency of Cryopreserved Human Amniotic membrane for the Treatment of Chronic Diabetic Foot Ulcers
- A Pilot, Prospective, Open-label, Randomized, Controlled Cross-Over Clinical Trial Comparing V.A.C. Therapy for the Treatment of Chronic Wounds versus Integrated Healing Technologies Negative Pressure Wound Therapy (IHT NPWT) Systems
- Efficacy of the Sciton Erbium Laser (Er:YAG) on Biofilm Reduction and Promotion of Wound Healing in Chronic Venous Stasis Ulcers
- Hyperbaric Oxygen Therapy in Management of Chronic Wounds: Analysis of Perfusion Using Indocyanine Green Angiography as a Biomarker to Predict Response to Treatment
- Multi-center Randomized Controlled Trial of dehydrated amnion and chorion membrane graft
Selected Peer-Reviewed Publications:
-
- Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment.
Journal: Plastic and Reconstructive Surgery. 2021 Jan 1; 147(1): 209-214 - Perfusion Assessment in Chronic Wounds.
Journal: Plastic and Reconstructive Surgery. 2022 Feb 1; 149(2): 347e - Hyperbaric Oxygen Therapy in Management of Chronic Wounds: In Search of a Potential Biomarker to Predict Response to Treatment.
Journal: Plastic and Reconstructive Surgery. 2021 Dec 1; 148(6): 1065e-1066e - Pressure Injury.
Journal: Annals of Surgery. 2020 Apr; 271(4): 671-679. - And at last, the Wound is Healed… or, is it?! In Search of an Objective Way to Predict the Recurrence of Diabetic Foot Ulcers.
Journal: Plastic and Reconstructive Surgery Glob Open. 2019 Apr; 7 (4 Suppl): 34-35. - Hyperbaric Oxygen Therapy: Descriptive Review of the Technology and Current Application in Chronic Wounds.
Journal: Plastic and Reconstructive Surgery Glob Open. 2020 Sep 25; 8(9): e3136. - Er:YAG Laser versus Sharp Debridement in Management of Chronic Wounds: Effects on Pain and Bacterial Load.
Journal: Wound Repair and Regeneration. 2020 Jan; 28(1): 118-125.
- Hyperbaric Oxygen Therapy in Management of Diabetic Foot Ulcers: Indocyanine Green Angiography May Be Used as a Biomarker to Analyze Perfusion and Predict Response to Treatment.
Selected Book Chapters:
